• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纵隔神经内分泌癌:食管鳞癌切除术后 8 年缓慢生长。

Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.

机构信息

Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan.

Department of Pathology, University of Tsukuba Hospital, Japan.

出版信息

Intern Med. 2020 Oct 15;59(20):2505-2509. doi: 10.2169/internalmedicine.4584-20. Epub 2020 Jul 7.

DOI:10.2169/internalmedicine.4584-20
PMID:32641665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7662036/
Abstract

A 70-year-old woman was referred to our department due to a solitary mediastinal tumor which gradually grew near the site of anastomosis for 8 years after radical surgery of esophageal squamous cell carcinoma. It was difficult to distinguish the lymph node recurrence of esophageal cancer from another tumor of unknown primary origin. Endoscopic ultrasound-guided fine-needle aspiration was performed, and the tumor was diagnosed to be neuroendocrine carcinoma. She received concurrent chemoradiotherapy with etoposide plus cisplatin. After the completion of chemoradiotherapy, the tumor disappeared. A solitary growing tumor which develops after radical resection of cancer would be better to be examined histologically in order to make an accurate diagnosis and select the most appropriate treatment.

摘要

一位 70 岁女性因孤立性纵隔肿瘤就诊,该肿瘤位于 8 年前行食管鳞癌根治术后吻合口附近,逐渐增大。难以将食管癌的淋巴结复发与不明原发灶的另一肿瘤区分开。行超声内镜引导下细针抽吸活检,诊断为神经内分泌癌。她接受依托泊苷联合顺铂同步放化疗。放化疗完成后,肿瘤消失。癌症根治性切除术后出现的孤立性生长肿瘤,最好进行组织学检查,以明确诊断并选择最合适的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/bc9d738e7ff1/1349-7235-59-2505-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/2e6134a2d768/1349-7235-59-2505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/6173d5b84186/1349-7235-59-2505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/9f97aa862c8d/1349-7235-59-2505-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/59d546f5cc7f/1349-7235-59-2505-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/87eabb3091d8/1349-7235-59-2505-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/bc9d738e7ff1/1349-7235-59-2505-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/2e6134a2d768/1349-7235-59-2505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/6173d5b84186/1349-7235-59-2505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/9f97aa862c8d/1349-7235-59-2505-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/59d546f5cc7f/1349-7235-59-2505-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/87eabb3091d8/1349-7235-59-2505-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8050/7662036/bc9d738e7ff1/1349-7235-59-2505-g006.jpg

相似文献

1
Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.纵隔神经内分泌癌:食管鳞癌切除术后 8 年缓慢生长。
Intern Med. 2020 Oct 15;59(20):2505-2509. doi: 10.2169/internalmedicine.4584-20. Epub 2020 Jul 7.
2
Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.根治性切除术后淋巴结复发的挽救性治疗。
Radiat Oncol. 2019 Sep 18;14(1):169. doi: 10.1186/s13014-019-1377-y.
3
[A Case of Lymph Node Recurrence with Invasion to the Trachea after the Resection of Esophageal Cancer Treated by Multidisciplinary Treatment].[一例多学科治疗食管癌切除术后淋巴结复发并侵犯气管的病例]
Gan To Kagaku Ryoho. 2019 Dec;46(13):2485-2487.
4
Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.胸段食管浅表鳞癌转移的临床特征。
Surgery. 2019 Dec;166(6):1033-1040. doi: 10.1016/j.surg.2019.07.022. Epub 2019 Sep 5.
5
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.一项 II/III 期随机对照临床试验,比较了手术后辅助放疗或同期放化疗与单纯手术治疗 IIB/III 期食管鳞癌患者的效果。
BMC Cancer. 2020 Feb 18;20(1):130. doi: 10.1186/s12885-020-6592-2.
6
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.局部晚期食管神经内分泌癌采用放化疗治疗的临床结果。
Cancer Med. 2020 Jan;9(2):595-604. doi: 10.1002/cam4.2708. Epub 2019 Dec 3.
7
The utility of EBUS-TBNA in the diagnosis of suspected intrathoracic recurrence after esophageal cancer surgery.超声支气管镜引导经支气管针吸活检术(EBUS-TBNA)在诊断食管癌手术后疑似胸内复发中的应用。
Jpn J Clin Oncol. 2020 May 5;50(5):602-608. doi: 10.1093/jjco/hyz212.
8
Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy.姑息性放疗后经全身化疗成功治疗的纵隔大细胞神经内分泌癌
Intern Med. 2019 Feb 15;58(4):563-568. doi: 10.2169/internalmedicine.0437-17. Epub 2018 Oct 17.
9
Composite neuroendocrine carcinoma and squamous cell carcinoma with regional lymph node metastasis: a case report.伴有区域淋巴结转移的复合性神经内分泌癌和鳞状细胞癌:一例报告
J Med Case Rep. 2018 Aug 24;12(1):227. doi: 10.1186/s13256-018-1775-z.
10
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression.一例原发性不明的神经内分泌肿瘤,其根据肿瘤分级进展对治疗产生反应。
Intern Med. 2019 Apr 15;58(8):1087-1091. doi: 10.2169/internalmedicine.1809-18. Epub 2018 Dec 18.

本文引用的文献

1
[Endocrine cell carcinoma of the esophagus without recurrence for more than 7 years after chemoradiotherapy].
Nihon Shokakibyo Gakkai Zasshi. 2019;116(1):71-79. doi: 10.11405/nisshoshi.116.71.
2
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.免疫结构、免疫评分和恶性细胞分子亚群在癌症预后和治疗分类中的应用。
Adv Immunol. 2016;130:95-190. doi: 10.1016/bs.ai.2015.12.002. Epub 2016 Jan 29.
3
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.ENETS关于肠道、胰腺、支气管神经内分泌肿瘤(NEN)及原发部位不明的NEN远处转移疾病管理的共识指南更新
Neuroendocrinology. 2016;103(2):172-85. doi: 10.1159/000443167. Epub 2016 Jan 5.
4
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.晚期消化系统神经内分泌癌全身化疗的多中心回顾性分析
Cancer Sci. 2014 Sep;105(9):1176-81. doi: 10.1111/cas.12473. Epub 2014 Sep 6.
5
Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas.伊立替康与铂类药物联合用于低分化神经内分泌癌
Rare Tumors. 2013 Sep 4;5(3):e39. doi: 10.4081/rt.2013.e39. eCollection 2013.
6
Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas.联合顺铂加伊立替康化疗治疗胃肠胰神经内分泌癌的可行性和疗效。
Med Oncol. 2013;30(3):664. doi: 10.1007/s12032-013-0664-y. Epub 2013 Jul 18.
7
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.305 例晚期胃肠神经内分泌癌(WHO G3)患者治疗和生存的预测和预后因素:北欧 NEC 研究。
Ann Oncol. 2013 Jan;24(1):152-60. doi: 10.1093/annonc/mds276. Epub 2012 Sep 11.
8
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.类癌肿瘤:根据转移部位预测原发肿瘤的位置。
Eur Radiol. 2013 Feb;23(2):400-7. doi: 10.1007/s00330-012-2615-y. Epub 2012 Aug 30.
9
Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.胃神经内分泌肿瘤:顺铂联合伊立替康化疗对胃低分化神经内分泌癌有效。
Gastric Cancer. 2011 Jun;14(2):161-5. doi: 10.1007/s10120-011-0025-5. Epub 2011 Feb 16.
10
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.顺铂和依托泊苷作为一线化疗药物用于治疗肝胆胰神经内分泌癌低分化患者。
Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4.